Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-16
DOI
10.3389/fmed.2021.651249
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus
- (2020) Ioannis Parodis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week long therapy in patients with SLE
- (2020) Alexander Borg et al. RHEUMATOLOGY
- All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971–2013)
- (2019) Konstantinos Tselios et al. ANNALS OF THE RHEUMATIC DISEASES
- Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus
- (2019) Ioannis Parodis et al. RHEUMATOLOGY
- History of fatigue in multiple sclerosis is associated with grey matter atrophy
- (2019) Miklos Palotai et al. Scientific Reports
- The impact of belimumab and rituximab on health-related quality of life in patients with systemic lupus erythematosus
- (2018) Ioannis Parodis et al. ARTHRITIS CARE & RESEARCH
- The relationship between remission and health-related quality of life in a cohort of SLE patients
- (2018) Michel W P Tsang-A-Sjoe et al. RHEUMATOLOGY
- Long-term impact of belimumab on health-related quality of life and fatigue in patients with systemic lupus erythematosus: 6 years of treatment
- (2018) Vibeke Strand et al. ARTHRITIS CARE & RESEARCH
- Disease-specific quality of life in patients with lupus nephritis
- (2017) M Jolly et al. LUPUS
- Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus
- (2017) M Piga et al. LUPUS
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- (2017) Caroline Gordon et al. RHEUMATOLOGY
- Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study
- (2017) William Stohl et al. Arthritis & Rheumatology
- Most patients who reach disease remission following anti-TNF therapy continue to report fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
- (2016) Katie L. Druce et al. RHEUMATOLOGY
- The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus
- (2016) Myles J. Lewis et al. RHEUMATOLOGY
- Remaining Pain in Early Rheumatoid Arthritis Patients Treated With Methotrexate
- (2016) Reem Altawil et al. ARTHRITIS CARE & RESEARCH
- Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus
- (2015) Mathilda Björk et al. BMC MUSCULOSKELETAL DISORDERS
- Patients receiving anti-TNF therapies experience clinically important improvements in RA-related fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
- (2014) Katie L. Druce et al. RHEUMATOLOGY
- Illness perceptions and psychological distress associated with physical health-related quality of life in primary Sjögren’s syndrome compared to systemic lupus erythematosus and rheumatoid arthritis
- (2014) Konstantinos Kotsis et al. RHEUMATOLOGY INTERNATIONAL
- Association of Health-Related Quality of Life in Childhood-Onset Systemic Lupus Erythematosus With Ethnicity: Results From a Multiethnic Multicenter Canadian Cohort
- (2014) Deborah M. Levy et al. ARTHRITIS CARE & RESEARCH
- Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials
- (2013) Vibeke Strand et al. ANNALS OF THE RHEUMATIC DISEASES
- Predictors of self-reported health-related quality of life in systemic lupus erythematosus
- (2013) A. N. Kiani et al. RHEUMATOLOGY
- Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
- (2012) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial
- (2012) Ronald F van Vollenhoven et al. LANCET
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- LupusQoL-US Benchmarks for US Patients with Systemic Lupus Erythematosus
- (2010) M. JOLLY et al. JOURNAL OF RHEUMATOLOGY
- Factors influencing the health related quality of life in patients with systemic lupus erythematosus: long-term results (2001—2005) of patients in the German Lupus Erythematosus Self-Help Organization (LULA Study)
- (2010) T. Tamayo et al. LUPUS
- The geoepidemiology of systemic lupus erythematosus
- (2009) Andrea T. Borchers et al. AUTOIMMUNITY REVIEWS
- Steroid-sparing effects of methotrexate in systemic lupus erythematosus: A double-blind, randomized, placebo-controlled trial
- (2008) Paul R. Fortin et al. ARTHRITIS AND RHEUMATISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started